Denosumab Market, Global Outlook and Forecast 2022-2028

April 2022 | 65 pages | ID: D63EBC197265EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Denosumab in Global, including the following market information:

Global Denosumab Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Denosumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

60 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Denosumab include Amgen, Qilu Pharmaceutical, Shandong Boan Biotech and Shanghai Mabwell, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Denosumab companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Denosumab Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Denosumab Market Segment Percentages, by Type, 2021 (%)

• 60 mg
• 120 mg

Global Denosumab Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Denosumab Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Denosumab Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Denosumab Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Denosumab revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Denosumab revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amgen
• Qilu Pharmaceutical
• Shandong Boan Biotech
• Shanghai Mabwell

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Denosumab Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Denosumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DENOSUMAB OVERALL MARKET SIZE

2.1 Global Denosumab Market Size: 2021 VS 2028
2.2 Global Denosumab Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Denosumab Players in Global Market
3.2 Top Global Denosumab Companies Ranked by Revenue
3.3 Global Denosumab Revenue by Companies
3.4 Top 3 and Top 5 Denosumab Companies in Global Market, by Revenue in 2021
3.5 Global Companies Denosumab Product Type
3.6 Tier 1, Tier 2 and Tier 3 Denosumab Players in Global Market
  3.6.1 List of Global Tier 1 Denosumab Companies
  3.6.2 List of Global Tier 2 and Tier 3 Denosumab Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Denosumab Market Size Markets, 2021 & 2028
  4.1.2 60 mg
  4.1.3 120 mg
4.2 By Type - Global Denosumab Revenue & Forecasts
  4.2.1 By Type - Global Denosumab Revenue, 2017-2022
  4.2.2 By Type - Global Denosumab Revenue, 2023-2028
  4.2.3 By Type - Global Denosumab Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Denosumab Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Denosumab Revenue & Forecasts
  5.2.1 By Application - Global Denosumab Revenue, 2017-2022
  5.2.2 By Application - Global Denosumab Revenue, 2023-2028
  5.2.3 By Application - Global Denosumab Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Denosumab Market Size, 2021 & 2028
6.2 By Region - Global Denosumab Revenue & Forecasts
  6.2.1 By Region - Global Denosumab Revenue, 2017-2022
  6.2.2 By Region - Global Denosumab Revenue, 2023-2028
  6.2.3 By Region - Global Denosumab Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Denosumab Revenue, 2017-2028
  6.3.2 US Denosumab Market Size, 2017-2028
  6.3.3 Canada Denosumab Market Size, 2017-2028
  6.3.4 Mexico Denosumab Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Denosumab Revenue, 2017-2028
  6.4.2 Germany Denosumab Market Size, 2017-2028
  6.4.3 France Denosumab Market Size, 2017-2028
  6.4.4 U.K. Denosumab Market Size, 2017-2028
  6.4.5 Italy Denosumab Market Size, 2017-2028
  6.4.6 Russia Denosumab Market Size, 2017-2028
  6.4.7 Nordic Countries Denosumab Market Size, 2017-2028
  6.4.8 Benelux Denosumab Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Denosumab Revenue, 2017-2028
  6.5.2 China Denosumab Market Size, 2017-2028
  6.5.3 Japan Denosumab Market Size, 2017-2028
  6.5.4 South Korea Denosumab Market Size, 2017-2028
  6.5.5 Southeast Asia Denosumab Market Size, 2017-2028
  6.5.6 India Denosumab Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Denosumab Revenue, 2017-2028
  6.6.2 Brazil Denosumab Market Size, 2017-2028
  6.6.3 Argentina Denosumab Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Denosumab Revenue, 2017-2028
  6.7.2 Turkey Denosumab Market Size, 2017-2028
  6.7.3 Israel Denosumab Market Size, 2017-2028
  6.7.4 Saudi Arabia Denosumab Market Size, 2017-2028
  6.7.5 UAE Denosumab Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amgen
  7.1.1 Amgen Corporate Summary
  7.1.2 Amgen Business Overview
  7.1.3 Amgen Denosumab Major Product Offerings
  7.1.4 Amgen Denosumab Revenue in Global Market (2017-2022)
  7.1.5 Amgen Key News
7.2 Qilu Pharmaceutical
  7.2.1 Qilu Pharmaceutical Corporate Summary
  7.2.2 Qilu Pharmaceutical Business Overview
  7.2.3 Qilu Pharmaceutical Denosumab Major Product Offerings
  7.2.4 Qilu Pharmaceutical Denosumab Revenue in Global Market (2017-2022)
  7.2.5 Qilu Pharmaceutical Key News
7.3 Shandong Boan Biotech
  7.3.1 Shandong Boan Biotech Corporate Summary
  7.3.2 Shandong Boan Biotech Business Overview
  7.3.3 Shandong Boan Biotech Denosumab Major Product Offerings
  7.3.4 Shandong Boan Biotech Denosumab Revenue in Global Market (2017-2022)
  7.3.5 Shandong Boan Biotech Key News
7.4 Shanghai Mabwell
  7.4.1 Shanghai Mabwell Corporate Summary
  7.4.2 Shanghai Mabwell Business Overview
  7.4.3 Shanghai Mabwell Denosumab Major Product Offerings
  7.4.4 Shanghai Mabwell Denosumab Revenue in Global Market (2017-2022)
  7.4.5 Shanghai Mabwell Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Denosumab Market Opportunities & Trends in Global Market
Table 2. Denosumab Market Drivers in Global Market
Table 3. Denosumab Market Restraints in Global Market
Table 4. Key Players of Denosumab in Global Market
Table 5. Top Denosumab Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Denosumab Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Denosumab Revenue Share by Companies, 2017-2022
Table 8. Global Companies Denosumab Product Type
Table 9. List of Global Tier 1 Denosumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Denosumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Denosumab Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Denosumab Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Denosumab Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Denosumab Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Denosumab Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Denosumab Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Denosumab Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Denosumab Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Denosumab Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Denosumab Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Denosumab Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Denosumab Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Denosumab Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Denosumab Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Denosumab Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Denosumab Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Denosumab Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Denosumab Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Denosumab Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Denosumab Product Offerings
Table 32. Amgen Denosumab Revenue (US$, Mn), (2017-2022)
Table 33. Qilu Pharmaceutical Corporate Summary
Table 34. Qilu Pharmaceutical Denosumab Product Offerings
Table 35. Qilu Pharmaceutical Denosumab Revenue (US$, Mn), (2017-2022)
Table 36. Shandong Boan Biotech Corporate Summary
Table 37. Shandong Boan Biotech Denosumab Product Offerings
Table 38. Shandong Boan Biotech Denosumab Revenue (US$, Mn), (2017-2022)
Table 39. Shanghai Mabwell Corporate Summary
Table 40. Shanghai Mabwell Denosumab Product Offerings
Table 41. Shanghai Mabwell Denosumab Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Denosumab Segment by Type in 2021
Figure 2. Denosumab Segment by Application in 2021
Figure 3. Global Denosumab Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Denosumab Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Denosumab Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Denosumab Revenue in 2021
Figure 8. By Type - Global Denosumab Revenue Market Share, 2017-2028
Figure 9. By Application - Global Denosumab Revenue Market Share, 2017-2028
Figure 10. By Region - Global Denosumab Revenue Market Share, 2017-2028
Figure 11. By Country - North America Denosumab Revenue Market Share, 2017-2028
Figure 12. US Denosumab Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Denosumab Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Denosumab Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Denosumab Revenue Market Share, 2017-2028
Figure 16. Germany Denosumab Revenue, (US$, Mn), 2017-2028
Figure 17. France Denosumab Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Denosumab Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Denosumab Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Denosumab Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Denosumab Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Denosumab Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Denosumab Revenue Market Share, 2017-2028
Figure 24. China Denosumab Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Denosumab Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Denosumab Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Denosumab Revenue, (US$, Mn), 2017-2028
Figure 28. India Denosumab Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Denosumab Revenue Market Share, 2017-2028
Figure 30. Brazil Denosumab Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Denosumab Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Denosumab Revenue Market Share, 2017-2028
Figure 33. Turkey Denosumab Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Denosumab Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Denosumab Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Denosumab Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Denosumab Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Qilu Pharmaceutical Denosumab Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Shandong Boan Biotech Denosumab Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Shanghai Mabwell Denosumab Revenue Year Over Year Growth (US$, Mn) & (2017-2022)